This study is currently not recruiting participants.

Acquisition of Leftover Processed Specimens for Investigational Testing

Investigation of Automated Testing Systems for Chlamydia and Gonorrhea

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to provide GEN-PROBE with remnant APTIMA specimens for testing on their automated instruments such as the TIGRIS DTS System and/or PANTHER DTS System, with Gen-Probe Assays such as but not limited to FDA-cleared APTIMA Assay for Chlamydia trachomatis, APTIMA Assay for Neisseria gonorrhoeae, and/or APTIMA COMBO 2 Assay, a combination nucleic acid test for CT and GC.

Detailed description of study

The purpose of this study is to provide GEN-PROBE with remnant APTIMA specimens for testing on their automated instruments such as the TIGRIS DTS System and/or PANTHER DTS System, with Gen-Probe Assays such as but not limited to FDA-cleared APTIMA Assay for Chlamydia trachomatis, APTIMA Assay for Neisseria gonorrhoeae, and/or APTIMA COMBO 2 Assay, a combination nucleic acid test for CT and GC.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy
  • Age: 100 years or below
  • Gender: All

This study investigates the use of automated instruments to test for infections such as Chlamydia trachomatis and Neisseria gonorrhoeae. The purpose is to evaluate how well these instruments work with specific tests that detect the genetic material of these infections.

Participants will provide remnant specimens, which are leftover samples from previous tests, for analysis. These specimens will be tested using automated systems to check their effectiveness in identifying the infections.

  • Who can participate: The study is open to individuals who have provided remnant specimens from previous testing. Specific eligibility criteria are not detailed.
  • Study details: Participants in this study will not be required to undergo any additional procedures, as the focus is on using leftover specimens from previous tests. A placebo is not involved in this study.
Updated on 19 Feb 2024. Study ID: 1604575959

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team